← Open Payments lookup

MATTHEW PABIS: Open Payments

NPI 1376981589 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$66,656 in 191 payments from 23 companies in 2025. Trend: 2023 $23,500 · 2024 $61,290 · 2025 $66,656

Speaker / faculty: $35,540Honoraria: $23,975Food & beverage: $5,668Consulting: $940Travel & lodging: $534
CompanyPaymentsAmount
Alkermes, Inc.35$34,973
Axsome Therapeutics, Inc.31$25,224
Otsuka Pharmaceutical Development & Commercialization, Inc.5$3,465
Gilead Sciences, Inc.29$743
ViiV Healthcare Company18$500
Janssen Scientific Affairs, LLC1$200
Lundbeck LLC11$178
Takeda Pharmaceuticals U.S.A., Inc.9$178
Janssen Pharmaceuticals, Inc2$160
Salix Pharmaceuticals, a division of Bausch Health US, LLC11$154

Products named: VIVITROL, Auvelity, APRETUDE, SPRAVATO, REXULTI, TRINTELLIX, RELISTOR, FANAPT.

Industry payments across NY — which companies pay providers there.